ACL Biomedical successfully held its 2026 Kick-Off Meeting today, hosted by Managing Director LiLi, bringing together all team members to reflect on the past year and set the direction for the year ahead.

During the meeting, LiLi led the team in reviewing key developments and transitions throughout 2025. In a dynamic and evolving market environment, the team demonstrated resilience and adaptability, strengthening collaboration and building a more solid foundation for future growth.

Following this, department leaders presented their 2025 performance highlights and outlined strategic plans for 2026. The presentations covered key areas including sales strategies and market expansion, new product development initiatives, as well as upcoming marketing campaigns and brand-building efforts. These discussions helped align the entire organization toward clear goals and execution priorities for the coming year.

After the meeting, a team lunch was arranged, providing an opportunity for colleagues to connect, exchange ideas, and celebrate together, bringing the event to a warm and meaningful close.

Looking ahead, ACL Biomedical will continue to strengthen team synergy, move forward with confidence, and pursue the next phase of growth with a clear and focused vision.